Patients not already receiving buprenorphine can receive the first injection of Sublocade following a single dose of transmucosal buprenorphine and a 1 hour observation period to confirm tolerability.

Guidance for 2025 projects total net revenue between $955M and $1.25B, reflecting a decline from 2024 due to erosion in SUBOXONE Film net revenue and the discontinuation of PERSERIS. SUBLOCADE’s 2025 ...

CEO Mark Crossley stated that Q1 financial results were in line with expectations, despite a 6% year-on-year decline in total net revenue, largely driven by intensified competition in SUBOXONE Film ...